Rosiglitazone infusion therapy following minimally invasive surgery for intracerebral hemorrhage evacuation decreases matrix metalloproteinase-9 and blood–brain barrier disruption in rabbits

BACKGROUND: The objective of this study was to investigate the effects of Rosiglitazone (RSG) infusion therapy following minimally invasive surgery (MIS) for intracerebral hemorrhage(ICH) evacuation on perihematomal secondary brain damage as assessed by MMP-9 levels, blood–brain barrier (BBB) permea...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Guofeng, Wu, Junjie, Jiao, Yu, Wang, Likun, Wang, Fan, Zhang, Yingjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472168/
https://www.ncbi.nlm.nih.gov/pubmed/26021445
http://dx.doi.org/10.1186/s12883-015-0287-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472168/
https://www.ncbi.nlm.nih.gov/pubmed/26021445
http://dx.doi.org/10.1186/s12883-015-0287-3

Ejemplares similares